Search - tctmd.com

Displaying 1 - 20 of 46

Sort: Relevancy | Date

News Industry News

Micell Technologies Announces First Patient Enrolled In Landmark Registration Trial of MiStent In Japan

November 29, 2016

News Industry News

Positive Five-Year Clinical Data from Micell Technologies’ MiStent Presented at TCT 2016

November 03, 2016

News Industry News TCT 2016

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

November 02, 2016

News Industry News

Micell Technologies Completes Enrollment in OCT Study Designed to Evaluate Superior Performance of MiStent SES Compared to Xience

March 22, 2016

News Industry News

Micell Technologies Highlights Data From Published Propensity Analysis of MiStent SES® and Market Standard Xience V® Coronary Stent

February 24, 2016

News Industry News

Micell Technologies Announces Completion of Enrollment in MiStent Randomized Trial Against Xience

December 08, 2015

News Industry News

Randomized Trial Of Diabetic Patients In India Finds Paclitaxel-Eluting Stents Failed To Meet Non-Inferiority Compared To Everolimus-Eluting Stents

October 14, 2015

News Industry News

Abbott Announces Positive Results Of Its Naturally Dissolving Stent From Absorb Japan Study

September 01, 2015

News Industry News

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

May 19, 2015

News Industry News

Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease

May 19, 2015

News Industry News

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

September 15, 2014

News Industry News

ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

September 14, 2014

News Industry News

Abbott Completes Enrollment of Absorb™ Randomized Clinical Trials in the United States, Japan and China

March 10, 2014

News Industry News

Boston Scientific Receives FDA Approval For Promus Premier™ Everolimus-Eluting Platinum Chromium Coronary Stent System

November 24, 2013

News Industry News

Abbott Announces Approval of Next-Generation XIENCE Xpedition™ Drug Eluting Stent System in Japan

July 10, 2013

News Industry News

Micell Technologies Receives CE Mark Approval for MiStent SES

June 12, 2013

News Industry News

Abbott Initiates Randomized Clinical Trial in Japan to Evaluate the Absorb™ Bioresorbable Vascular Scaffold

June 11, 2013

News Industry News

For Bifurcation Lesions in Coronary Arteries, Medtronic's Resolute Stent Delivers Strong Long-Term Results

May 22, 2013

News Industry News

Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent

May 21, 2013

News Industry News

Promus PREMIER™ Everolimus-Eluting Platinum Chromium Stent System Receives CE Mark Approval

February 11, 2013

Advertisement

Micell Technologies Announces First Patient Enrolled In Landmark Registration Trial of MiStent In Japan

Positive Five-Year Clinical Data from Micell Technologies’ MiStent Presented at TCT 2016

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

Micell Technologies Completes Enrollment in OCT Study Designed to Evaluate Superior Performance of MiStent SES Compared to Xience

Micell Technologies Highlights Data From Published Propensity Analysis of MiStent SES® and Market Standard Xience V® Coronary Stent

Micell Technologies Announces Completion of Enrollment in MiStent Randomized Trial Against Xience

Randomized Trial Of Diabetic Patients In India Finds Paclitaxel-Eluting Stents Failed To Meet Non-Inferiority Compared To Everolimus-Eluting Stents

Abbott Announces Positive Results Of Its Naturally Dissolving Stent From Absorb Japan Study

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

Abbott Completes Enrollment of Absorb™ Randomized Clinical Trials in the United States, Japan and China

Boston Scientific Receives FDA Approval For Promus Premier™ Everolimus-Eluting Platinum Chromium Coronary Stent System

Abbott Announces Approval of Next-Generation XIENCE Xpedition™ Drug Eluting Stent System in Japan

Micell Technologies Receives CE Mark Approval for MiStent SES

Abbott Initiates Randomized Clinical Trial in Japan to Evaluate the Absorb™ Bioresorbable Vascular Scaffold

For Bifurcation Lesions in Coronary Arteries, Medtronic's Resolute Stent Delivers Strong Long-Term Results

Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent

Promus PREMIER™ Everolimus-Eluting Platinum Chromium Stent System Receives CE Mark Approval

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content